Hot Investor Mandate 2: Big Pharma Firm Seeks Drugs and Devices in Cardiovascular, Immunology, Inflammation, Oncology, Neuro & Rare Diseases

29 Jun

A multinational biopharmaceutical corporation looks to invest in/partner with academic research and start-up companies for developing innovative therapies. The firm has established a number of partnering models, including a corporate venture fund. The firm also takes part in equity rounds, usually with rights attached. The firm is open to make co-development deals to help early-stage biotech companies, and is currently looking for new investment opportunities across the globe with a focus in North America, Europe, and Asia.

The firm is currently looking for innovative therapeutics and medical technologies targeting the following areas: Cardiovascular & Metabolic Diseases, Immunology & Inflammation, Neuroscience, Oncology, Rare Diseases, and Vaccines. The firm is also open to other life science technologies that may speed up the development process, including lab technology and drug development enabling technologies. The firm also seeks in-licensing products for development. Overall, the firm is open to all stages of development, as the firm has separate teams to encompass all phases of development from preclinical to commercial stages.

The firm collaborates, in multiple formats, with both privately held and public life science companies with experienced management teams, innovative technologies, and an established scientific unit.

If you are interested in more information about this investor and other investors tracked by LSN, please email

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: